Search Results - "SELNER, Milada"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells by Lang, T T, Selner, M, Young, J D, Cass, C E

    Published in Molecular pharmacology (01-11-2001)
    “…CEM-ARAC leukemia cells with resistance to cytarabine were shown to lack equilibrative transporter (hENT1) expression and activity. Stable transfer of hCNT2…”
    Get more information
    Journal Article
  2. 2

    Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines by MACKEY, J. R, MANI, R. S, SELNER, M, MOWLES, D, YOUNG, J. D, BELT, J. A, CRAWFORD, C. R, CASS, C. E

    Published in Cancer research (Chicago, Ill.) (01-10-1998)
    “…Gemcitabine (2',2'-difluorodeoxycytidine) is a novel pyrimidine nucleoside drug with clinical efficacy in several common epithelial cancers. We have proposed…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Differential activity of vincristine and vinblastine against cultured cells by FERGUSSON, P. J, PHILLIPS, J. R, SELNER, M, CASS, C. E

    Published in Cancer research (Chicago, Ill.) (01-08-1984)
    “…Vincristine and vinblastine exhibit differential activity against tumors and normal tissues. In this work, a number of cultured cell lines were assayed for…”
    Get full text
    Journal Article
  5. 5

    Effect of lithium on the myelosuppressive and chemotherapeutic activities of vinblastine by Cass, C E, Turner, A R, Selner, M, Allalunis, M J, Tan, T H

    Published in Cancer research (Chicago, Ill.) (01-03-1981)
    “…Serum concentrations of lithium after i.p. administration to normal mice declined with biphasic kinetics. Treatment of mice bearing ascitic L1210 leukemia with…”
    Get full text
    Journal Article